Healthcare provider profile · identity verified

Amber Hicks-Thibodeau

Family Practice · MOORESVILLE, NC · NPI 1063869469

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	407	108
Amlodipine Besylate	Amlodipine Besylate	365	103
Levothyroxine Sodium	Levothyroxine Sodium	353	86
Lisinopril	Lisinopril	307	96
Omeprazole	Omeprazole	251	73
Rosuvastatin Calcium	Rosuvastatin Calcium	223	79
Losartan Potassium	Losartan Potassium	205	66
Metformin Hcl	Metformin Hcl	182	49
Hydrochlorothiazide	Hydrochlorothiazide	172	46
Metoprolol Succinate	Metoprolol Succinate	142	45
Escitalopram Oxalate	Escitalopram Oxalate	136	46
Trazodone Hcl	Trazodone Hcl	134	37
Gabapentin	Gabapentin	132	28
Meloxicam	Meloxicam	114	29
Simvastatin	Simvastatin	110	34
Pantoprazole Sodium	Pantoprazole Sodium	107	39
Lorazepam	Lorazepam	102	15
Alprazolam	Alprazolam	101	19
Valsartan	Valsartan	98	30
Zolpidem Tartrate	Zolpidem Tartrate	98	22
Montelukast Sodium	Montelukast Sodium	96	29
Sertraline Hcl	Sertraline Hcl	95	28
Tizanidine Hcl	Tizanidine Hcl	95	22
Alendronate Sodium	Alendronate Sodium	88	27
Buspirone Hcl	Buspirone Hcl	88	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	23
Albuterol Sulfate Hfa	Albuterol Sulfate	85	26
Ezetimibe	Ezetimibe	81	30
Ozempic	Semaglutide	78	22
Tramadol Hcl	Tramadol Hcl	77	13
Jardiance	Empagliflozin	70	18
Methylprednisolone	Methylprednisolone	70	61
Famotidine	Famotidine	68	20
Metformin Hcl Er	Metformin Hcl	68	21
Metoprolol Tartrate	Metoprolol Tartrate	68	17
Furosemide	Furosemide	66	24
Pravastatin Sodium	Pravastatin Sodium	65	19
Clopidogrel	Clopidogrel Bisulfate	64	17
Tamsulosin Hcl	Tamsulosin Hcl	61	21
Fluticasone Propionate	Fluticasone Propionate	60	29
Duloxetine Hcl	Duloxetine Hcl	59	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	16
Eliquis	Apixaban	58	15
Mounjaro	Tirzepatide	58	14
Citalopram Hbr	Citalopram Hydrobromide	57	19
Donepezil Hcl	Donepezil Hcl	53	13
Meclizine Hcl	Meclizine Hcl	50	15
Potassium Chloride	Potassium Chloride	50	17
Bupropion Xl	Bupropion Hcl	48	12
Pregabalin	Pregabalin	45	suppressed
Mirtazapine	Mirtazapine	44	14
Acetaminophen-Codeine	Acetaminophen With Codeine	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	13
Celecoxib	Celecoxib	39	16
Temazepam	Temazepam	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	13
Farxiga	Dapagliflozin Propanediol	37	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	13
Atenolol	Atenolol	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Fenofibrate	Fenofibrate	33	12
Nifedipine Er	Nifedipine	33	11
Spironolactone	Spironolactone	33	11
Allopurinol	Allopurinol	32	11
Azithromycin	Azithromycin	32	27
Mupirocin	Mupirocin	32	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Glipizide Er	Glipizide	30	11
Lovastatin	Lovastatin	30	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Ondansetron Odt	Ondansetron	27	13
Valacyclovir	Valacyclovir Hcl	27	13
Hydroxyzine Hcl	Hydroxyzine Hcl	26	11
Cephalexin	Cephalexin	25	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Fluconazole	Fluconazole	22	18
Glipizide	Glipizide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	18
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	21	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Estradiol	Estradiol	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ramipril	Ramipril	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	12
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Nystatin	Nystatin	16	13
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Torsemide	Torsemide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Glimepiride	Glimepiride	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Verapamil Er	Verapamil Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error